Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase II study of perifosine in androgen independent prostate cancer.
Posadas EM, Gulley J, Arlen PM, Trout A, Parnes HL, Wright J, Lee MJ, Chung EJ, Trepel JB, Sparreboom A, Chen C, Jones E, Steinberg SM, Daniels A, Figg WD, Dahut WL. Posadas EM, et al. Cancer Biol Ther. 2005 Oct;4(10):1133-7. doi: 10.4161/cbt.4.10.2064. Epub 2005 Oct 1. Cancer Biol Ther. 2005. PMID: 16138006 Clinical Trial.
Chemoprevention in prostate cancer.
Parnes HL, Figg WD. Parnes HL, et al. Pharmacotherapy. 2006 Oct;26(10):1533; author reply 1533. doi: 10.1592/phco.26.10.1533. Pharmacotherapy. 2006. PMID: 16999665 No abstract available.
Early treatment gets the benefit.
Gulley JL, Parnes HL, Wright J, Dahut WL. Gulley JL, et al. J Clin Oncol. 2006 Nov 10;24(32):5172-3; author reply 5173. doi: 10.1200/JCO.2006.07.9053. J Clin Oncol. 2006. PMID: 17093283 No abstract available.
Clinical safety of a viral vector based prostate cancer vaccine strategy.
Arlen PM, Skarupa L, Pazdur M, Seetharam M, Tsang KY, Grosenbach DW, Feldman J, Poole DJ, Litzinger M, Steinberg SM, Jones E, Chen C, Marte J, Parnes H, Wright J, Dahut W, Schlom J, Gulley JL. Arlen PM, et al. Among authors: parnes h. J Urol. 2007 Oct;178(4 Pt 1):1515-20. doi: 10.1016/j.juro.2007.05.117. Epub 2007 Aug 16. J Urol. 2007. PMID: 17707059 Clinical Trial.
A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation.
Figg WD, Hussain MH, Gulley JL, Arlen PM, Aragon-Ching JB, Petrylak DP, Higano CS, Steinberg SM, Chatta GS, Parnes H, Wright JJ, Sartor O, Dahut WL. Figg WD, et al. Among authors: parnes h. J Urol. 2009 Mar;181(3):1104-13; discussion 1113. doi: 10.1016/j.juro.2008.11.026. Epub 2009 Jan 23. J Urol. 2009. PMID: 19167733 Free PMC article. Clinical Trial.
Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.
Aragon-Ching JB, Ning YM, Chen CC, Latham L, Guadagnini JP, Gulley JL, Arlen PM, Wright JJ, Parnes H, Figg WD, Dahut WL. Aragon-Ching JB, et al. Among authors: parnes h. Cancer Invest. 2009 Feb;27(2):221-6. doi: 10.1080/07357900802208608. Cancer Invest. 2009. PMID: 19235596 Free PMC article. Clinical Trial.
Challenges in clinical prostate cancer: role of imaging.
Kelloff GJ, Choyke P, Coffey DS; Prostate Cancer Imaging Working Group. Kelloff GJ, et al. AJR Am J Roentgenol. 2009 Jun;192(6):1455-70. doi: 10.2214/AJR.09.2579. AJR Am J Roentgenol. 2009. PMID: 19457806 Free PMC article.
172 results